Ignite Creation Date:
2024-05-06 @ 4:15 PM
Last Modification Date:
2024-10-26 @ 2:06 PM
Study NCT ID:
NCT04922788
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2022-11-04
First Post:
2021-06-08
Brief Title:
Study to Evaluate the Safety Immunogenicity and Efficacy of Nanocovax Vaccine Against COVID-19
Sponsor:
Nanogen Pharmaceutical Biotechnology Joint Stock Company
Organization:
Nanogen Pharmaceutical Biotechnology Joint Stock Company
Organization Data
Organization:
Nanogen Pharmaceutical Biotechnology Joint Stock Company
Class:
INDUSTRY
Study ID:
NNG27
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Nanogen Pharmaceutical Biotechnology Joint Stock Company
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None